Delcasertib, CAS 949100-39-4

Product Description: Delcasertib (KAI-9803) is a potent and selective δ-protein kinase C (δPKC) inhibitor. Delcasertib (KAI-9803) could ameliorate injury associated with ischemia and reperfusion in animal models of acute myocardial infarction (MI)[1][2].

Applications: COVID-19-immunoregulation

Formula: C120H199N45O34S2

References: [1]Miyaji Y, et al. Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats. Drug Metab Dispos. 2011 Oct;39(10):1946-53./[2]Bates E, et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Feb 19;117(7):886-96.

CAS Number: 949100-39-4

Molecular Weight: 2880.28

Compound Purity: 98.21

Research Area: Inflammation/Immunology; Cardiovascular Disease

Solubility: DMSO : ≥ 100 mg/mL

Target: PKC

• Artikelnummer: MEXHY-106262-50
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-106262-50
• Green Labware: Nein
• Verpackungseinheit: 50mg
• Mengeneinheit: STK